Wellesley, Mass. – In a recent release, ORGAN AND TISSUE TRANSPLANTATION AND ALTERNATIVES (HLC012E) from BCC Research (www.bccresearch.com), the global market for transplantation products and devices was worth $53.6 billion in 2010. That value is projected to be $79.8 billion in 2015, after increasing at a five-year compound annual growth rate (CAGR) of 8.3%.
The global market for transplantation products and devices can be broken down into five segments – tissue products, immunosuppressants, tissue typing technologies, solid organ preservation solutions, and alternative technologies.
The segment made up of tissue products was valued at nearly $15.6 billion in 2010, and in 2015 should be worth $26 billion, yielding a CAGR of 10.8%.
The segment made up of immunosuppressants, worth $8.9 billion in 2010, should rise to $13 billion in 2015, a CAGR of 7.9%.
The segment made up of tissue typing technologies was worth nearly $314 million in 2010 and in 2015 should be worth $553 million, a CAGR of 12%.
The segment made up of solid organ preservation solutions was worth $33.1 million in 2010 and in 2015 should be worth $42.3 million, a CAGR of 5%.
The segment made up of alternative technologies was worth $28.8 billion in 2010 and in 2015 should be worth $40.1 billion, a CAGR of 6.9%.
Organ transplantation is a dynamic field in which the development of artificial organs and transplantation methods aims to reduce the likelihood of rejection and infection. Transplantation is the last therapeutic option available to people in the final stage of an organ or tissue failure; the reality, however, is that the supply of organs or tissues is so limited that for the vast majority of people, transplantation is not an option. Despite this lack of supply, the transplantation business continues to innovate through better harvesting and procurement techniques, vastly improved immunosuppression regimens, advanced tissue matching, and effective anti-infective regimens.
The global organ and tissue transplantation market contains elements of both a mature market and an evolving market. Experimental for most of the 1900s, successful organ and tissue transplantation finally came to fruition in the 1970s when tissue typing coupled with the use of cyclosporine provided more successful grafting and patient survival. Since then, the transplantation industry has continued to evolve and gain widespread acceptance. One major key to the success and growth of the transplant market is the donation of more organs for transplantation, as demand is rapidly growing.
This report is a valuable tool for anyone assessing the organ and tissue transplantation market and attempting to devise a strategy to successfully compete within the market. The report also is a valuable tool for business planners, acquisitions specialists, licensing strategists, product managers, market research analysts, investing consultants, and others interested in the tissue and transplantation market.
Organ and Tissue Transplantation and Alternatives( HLC012E )
Publish Date: January 2011
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC, 49 Walnut Park, Building 2, Wellesley, MA 02481, Telephone: 866-285-7215; Email: firstname.lastname@example.org as the source and publisher. Thank you.